A Multicenter, Multinational, Cohort Long-term Post-market Clinical Follow-up (PMCF) of the Safety and Efficacy of the Osseoanchored Prostheses for the Rehabilitation of Amputees (OPRA) Implant System When Used for Transhumeral Implantation in Amputee Patients
Ориентир для пациента и семьи
Простыми словами
Автоматическая сводка по структурированным данным реестра. Она помогает сориентироваться, но не заменяет официальный протокол или оценку врача.
- Что изучают
- В протоколе указаны: OPRA transhumeral.
- Кому может быть актуально
- Состояния в реестре: Amputation of Upper Limb. Базовые параметры: Без ограничений · Все.
- Что важно проверить
- Возраст, диагноз и пол — только базовые ориентиры. Предыдущее лечение, анализы и другие обязательные условия указаны ниже в критериях участия.
- Где проводится
- Австралия, Австрия, Бельгия, Германия, Нидерланды
- Следующий шаг
- Сохраните исследование, покажите его лечащему врачу и уточните актуальный статус у исследовательского центра. Расходы, документы и поездка →
Не всё понятно в терминах? Прочитайте наш гид для пациентов →
Обзор
This non-interventional clinical investigation is initiated for the purpose of long-term Post-Market Clinical Follow-up (PMCF) and the follow-up time of patients is expected to span from 6 months to \>20 years in function. It will collect and evaluate clinical data on the safety and performance of the OPRA™ Implant System when used on transhumeral amputees and within the scope of the intended use.
Подробное описание
All subjects that will be enrolled in this investigation should have been treated with the OPRA Implant System for a transhumeral unilateral or bilateral amputation and completed the second stage surgery (S2) and had at least 6 months of usage experience with the OPRA Implant System before enrolment.
This retrospective, non-interventional, clinical investigation is designed as a multicenter, multinational, cohort investigation for long-term follow-up of safety and efficacy endpoints. The investigation will also include prospective visit(s) for enrollment of subjects and collection of present data on device functionality and the use of the device.
No control group or comparator will be used in this investigation.
All patient reported outcome questionnaires used in the investigation will be available at the investigation site for completion by the subjects during one of the subjects' visits to the site. Depending on the subjects' preferences it will also be possible to provide those questionnaires to the subjects, through use of regular mail, email or through an electronic Patient Reported Outcome system (ePRO). It will be possible for the subjects to complete the questionnaires either on paper, electronically or over phone, depending on their preferences.
Preferably, the subjects prosthesis functional tests should be performed as part of the follow-up visit at the site. The tests may also be performed remotely, depending on subjects' preferences. If done remotely, this will require the functionality test being performed during a videoconference with the test administrator. No photos or video-recordings (if conducted according to the sites normal practice) of the performed tests will be part of the investigation documentation, only the related medical record notes will be used as source data for those parameters.
Вмешательства
- Устройство OPRA transhumeral
Skeletal anchorage of amputation prostheses.
Первичные конечные точки
- Implant Safety and Effectivness [Срок оценки: 2 years post implant surgery]
Вторичные конечные точки (12)
- Implant Safety [Срок оценки: More than 10 years]
- Implant Safety [Срок оценки: More than 10 years]
- Implant safety [Срок оценки: More than 10 years]
- Implant safety [Срок оценки: More than 10 years]
- Implant effectiveness [Срок оценки: 6 months, 1yr, 2yrs, 5yrs, 10yrs, > 10yrs]
- Implant effectiveness [Срок оценки: 6 months, 1yr, 2yrs, 5yrs, 10yrs, >10yrs]
- Implant effectivness [Срок оценки: 6 months, 1yr, 2yrs, 5yrs, 10yrs, >10yrs]
- Implant effectiveness [Срок оценки: Through study completion, an avarage of approximately 1 month.]
- Implant effectivness [Срок оценки: Through study completion, an avarage of approximately 1 month.]
- Implant effectivness. [Срок оценки: Through study completion, an avarage of approximately 1 month.]
- Implant effectiveness [Срок оценки: Through study completion, an avarage of approximately 1 month.]
- Implant effectivness [Срок оценки: Through study completion, an avarage of approximately 1 month.]
Критерии участия
Критерии включения
- Unilateral or bilateral amputation
- OPRA™ implant system placed, and with S2 completed before 01-Jan-2024
- Having a minimum of 6 months of follow-up between S2 and enrolment
Критерии исключения
- Subject not willing to consent
- Subject implanted with the e-OPRA system at the humeral level.
Критерии приведены из реестра в оригинале (на английском). Окончательную оценку соответствия проводит исследовательский центр.
Здоровые добровольцы: Нет
Дизайн исследования
- Распределение
- Не применимо
- Модель
- Одна группа
- Маскирование
- Открытое
- Основная цель
- Лечение
Центры проведения
Германия · 2 центра
- Hannover Medical School — Hanover
- University Hospital Tübing — Tübingen
Австралия · 1 центр
- The Alfred Hospital — Melbourne
Австрия · 1 центр
- Medical University of Vienna Clinical laboratory for bionic limb reconstruction Währinger — Vienna
Бельгия · 1 центр
- University Hospital Ghent, UX Ghent — Ghent
Нидерланды · 1 центр
- University Medical Center Groningen — Groningen
Идентификаторы
NCT: NCT06753110 · 0092